Ma S, Chen J, Feng J, et al. Melatonin ameliorates the progression of atherosclerosis via mitophagy activation and NLRP3 inflammasome inhibition. Oxid Med Cell Longev 2018; 2018: 9286458.
[10] Zhou H, Zhu P, Guo J, et al. Ripk3 induces mitochondrial apoptosis via inhibition of FUNDC1 mitophagy in cardiac IR injury. Redox Biol 2017; 13: 498−507. doi: 10.1016/j.redox.2017.07.007 [11] Chester C, Sanmamed MF, Wang J, et al. Immunotherapy targeting 4-1BB: mechanistic rationale, clinical results, and future strategies. Blood 2018; 131: 49−57. doi: 10.1182/blood-2017-06-741041 [12]Kamijo H, Miyagaki T, Shishido-Takahashi N, et al. Aberrant CD137 ligand expression induced by GATA6 overexpression promotes tumor progression in cutaneous T-cell lymphoma. Blood 2018; 132: 1922−1935.
[13]Kim HJ, Lee JS, Kim JD, et al. Reverse signaling through the costimulatory ligand CD137L in epithelial cells is essential for natural killer cell-mediated acute tissue inflammation. Proc Natl Acad Sci U S A 2012; 109: e13−e22.
[14] Mouton AJ, Ma Y, Rivera Gonzalez OJ, et al. Fibroblast polarization over the myocardial infarction time continuum shifts roles from inflammation to angiogenesis. Basic Res Cardiol 2019; 114: 6. doi: 10.1007/s00395-019-0715-4 [15]Weng J, Wang C, Zhong W, et al. Activation of CD137 Signaling Promotes Angiogenesis in Atherosclerosis via Modulating Endothelial Smad1/5-NFATc1 Pathway. J Am Heart Assoc 2017; 6.
[16] Zhong W, Li B, Xu Y, et al. Hypermethylation of the micro-RNA 145 promoter is the key regulator for NLRP3 inflammasome-induced activation and plaque formation. JACC Basic Transl Sci 2018; 3: 604−624. doi: 10.1016/j.jacbts.2018.06.004 [17] Xu Y, Yan Y, Geng T, et al. CD137-CD137L signaling affects angiogenesis by mediating phenotypic conversion of macrophages. J Cardiovasc Pharmacol 2020; 75: 148−154. doi: 10.1097/FJC.0000000000000772 [18] Chen Y, Bangash AB, Song J, et al. Activation of CD137 signaling accelerates vascular calcification in vivo and vitro. Int J Cardiol 2017; 230: 198−203. doi: 10.1016/j.ijcard.2016.12.174 [19] Gao E, Lei YH, Shang X, et al. A novel and efficient model of coronary artery ligation and myocardial infarction in the mouse. Circ Res 2010; 107: 1445−1453. doi: 10.1161/CIRCRESAHA.110.223925 [20] Bortolotti P, Faure E, Kipnis E. Inflammasomes in tissue damages and immune disorders after trauma. Front Immunol 2018; 9: 1900. doi: 10.3389/fimmu.2018.01900 [21]Lin Q, Li S, Jiang N, et al. Inhibiting NLRP3 inflammasome attenuates apoptosis in contrast-induced acute kidney injury through the upregulation of HIF1A and BNIP3-mediated mitophagy. Autophagy 2020: 1-16.
[22]Shokoples BG, Paradis P, Schiffrin EL. P2X7 receptors: an untapped target for the management of cardiovascular disease. Arterioscler Thromb Vasc Biol 2021; 41: 186−199.
[23] Hofmann U, Frantz S. Role of T-cells in myocardial infarction. Eur Heart J 2016; 37: 873−879. doi: 10.1093/eurheartj/ehv639 [24] Thorgersen EB, Barratt-Due A, Haugaa H, et al. The role of complement in liver injury, regeneration, and transplantation. Hepatology 2019; 70: 725−736. doi: 10.1002/hep.30508 [25] Ponticelli C, Campise MR. The inflammatory state is a risk factor for cardiovascular disease and graft fibrosis in kidney transplantation. Kidney Int 2021; 100: 536−545. doi: 10.1016/j.kint.2021.04.016 [26] [27] Arslan F, Smeets MB, O'Neill LA, et al. Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody. Circulation 2010; 121: 80−90. doi: 10.1161/CIRCULATIONAHA.109.880187 [28] Nazir S, Gadi I, Al-Dabet MM, et al. Cytoprotective activated protein C averts Nlrp3 inflammasome-induced ischemia-reperfusion injury via mTORC1 inhibition. Blood 2017; 130: 2664−2677. doi: 10.1182/blood-2017-05-782102 [29] Joshi AU, Minhas PS, Liddelow SA, et al. Fragmented mitochondria released from microglia trigger A1 astrocytic response and propagate inflammatory neurodegeneration. Nat Neurosci 2019; 22: 1635−1648. doi: 10.1038/s41593-019-0486-0 [30] Zhou R, Yazdi AS, Menu P, et al. A role for mitochondria in NLRP3 inflammasome activation. Nature 2011; 469: 221−225. doi: 10.1038/nature09663 [31] Lin Q, Li S, Jiang N, et al. PINK1-parkin pathway of mitophagy protects against contrast-induced acute kidney injury via decreasing mitochondrial ROS and NLRP3 inflammasome activation. Redox Biol 2019; 26: 101254. doi: 10.1016/j.redox.2019.101254
留言 (0)